Table 3.
Immunocompromised children | Immunocompetent children | p valuea | |
---|---|---|---|
N = 93 | N = 1170 | ||
n (%) or median (IQR) | n (%) or median (IQR) | ||
Demographic data | |||
Gender male | 44 (47.3) | 645 (55.1) | 0.089 |
Age (years) | 4.0 (2.0–6.0) | 3.0 (1.0–5.0) | 0.006** |
Age groups | |||
0–4 years | 58 (62.4) | 798 (68.2) | 0.493 |
5–9 years | 29 (31.2) | 302 (25.8) | |
10–16 years | 6 (6.5) | 70 (6.0) | |
Hospital stay and outcome | |||
With varicella-related complication | 48 (51.6) | 906 (77.4) | < 0.001*** |
Varicella infection/complication main reason for hospital admission | 51 (54.8) | 1031 (88.1) | < 0.001*** |
Duration of hospital stay (days) | 5.0 (3.5-9.0) | 3.0 (2.0–6.0) | < 0.001*** |
Complex intensive care treatment | 0 (0.0) | 5 (0.4) | 0.682 |
Fatalities | 1 (1.1) | 1 (0.1) | 0.142 |
***Significant at 0.1% level, **significant at 1% level, *significant at 5% level
ap value for comparison of children hospitalized with varicella with and without a specific complication; Pearson’s Chi2 or Fisher’s exact test as appropriate and Mann-Whitney U test for continuous variables